Decalcified bone matrix and lentivirus-mediated silencing of P75 neurotrophin receptor transfected bone marrow mesenchymal stem cells to construct tissue-engineered bone

doi:10.3969/j.issn.2095-4344.2361

Abstract

Abstract: BACKGROUND: P75 neurotrophin receptor (P75NTR) has a bidirectional role in promoting and inhibiting bone formation in bone tissue. Overexpression of P75NTR can inhibit the osteogenic mineralization of bone marrow mesenchymal stem cells. P75NTR can inhibit the degradation of fibrin and the formation of new blood vessels around the fracture, leading to fracture nonunion. Its inhibition of bone tissue repair is related to its mediating apoptosis channels.
OBJECTIVE: To study the effect of silencing P75NTR on the growth activity and alkaline phosphatase activity of bone marrow mesenchymal stem cells, and to study the ectopic osteogenesis ability implanted in demineralized bone matrix to construct tissue engineering bone complex.
METHODS: Lentivirus-mediated silencing P75NTR was transfected into bone marrow mesenchymal stem cells. The expression of fluorescent protein and P75NTR protein was detected by fluorescence inverted phase contrast microscope and western blot assay. Two or three days after transfection, CCK-8 assay was used to detect cell activity. After osteogenic induction solution induced differentiation culture for 7 and 14 days, alkaline phosphatase activity was detected by enzyme labeling method. Lentivirus-mediated silencing P75NTR transfected bone marrow mesenchymal stem cells were cultured with compound demineralized bone matrix. Optical inverted phase contrast microscope and scanning electron microscope were used to observe the adhesion of demineralized bone matrix and bone marrow mesenchymal stem cells. After further osteogenic differentiation for 7 days, tissue engineered bone complex was subcutaneously implanted in the rat back for 4 weeks. The osteogenesis was observed by hematoxylin-eosin staining and alkaline phosphatase staining.
RESULTS AND CONCLUSION: (1) Lentiviral-mediated silencing P75NTR transfection rate was approximately 70%. The expression of P75NTR target protein was significantly lower than that of untransfected group and negative virus control group (P < 0.05). (2) Compared with untransfected group and negative virus control group, the cell activity of silencing P75NTR transfected group increased significantly at 5 and 6 days (P < 0.05). Compared with the untransfected group and the negative virus control group, the alkaline phosphatase activity of silencing P75NTR transfected group increased significantly at 7 and 14 days after osteogenic induction (P < 0.05). (3) Silencing P75NTR transfected bone marrow mesenchymal stem cells and demineralized bone matrix formed a good adhesion; the tissue engineered bone complex significantly enhanced the ability of ectopic bone formation. (4) The results showed that bone marrow mesenchymal stem cells transfected with silencing P75NTR mediated by lentivirus could be implanted in decalcified bone matrix to form a good tissue engineered bone complex, which has a certain heterotopic osteogenesis effect and provides important theoretical basis for bone tissue engineering in the treatment of bone defects.

Key words: stem cells, bone marrow mesenchymal stem cells, materials, factors, ectopic, osteogenesis, rats, lentivirus

CLC Number:

Chen Junyi, Wang Ning, Peng Chengfei, Zhu Lunjing, Duan Jiangtao, Wang Ye, Bei Chaoyong. Decalcified bone matrix and lentivirus-mediated silencing of P75 neurotrophin receptor transfected bone marrow mesenchymal stem cells to construct tissue-engineered bone[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(4): 510-515.

Figures/Tables 9

References

[1] GÓMEZ-BARRENA E, ROSSET P, LOZANO D, et al. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015;70:93-101.
[2] BLÖCHL A, BLUMENSTEIN L, AHMADIAN MR. Inactivation and activation of Ras by the neurotrophin receptor p75. Eur J Neurosci. 2004;20(9): 2321-2335.
[3] COLE HA, OHBA T, NYMAN JS, et al. Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Arthritis Rheumatol. 2014;66(8):2222-2233.
[4] NYKJAER A, WILLNOW TE. Sortilin: a receptor to regulate neuronal viability and function. Trends Neurosci. 2012;35(4):261-270.
[5] TWISS JL, CHANG JH, SCHANEN NC. Pathophysiological mechanisms for actions of the neurotrophins. Brain Pathol. 2006;16(4):320-332.
[6] ALDER J, FUJIOKA W, GIARRATANA A, et al. Genetic and pharmacological intervention of the p75NTR pathway alters morphological and behavioural recovery following traumatic brain injury in mice. Brain Inj. 2016;30(1):48-65.
[7] SHEN J, CHEN X, LI H, et al. p75 neurotrophin receptor and its novel interaction partner, NIX, are involved in neuronal apoptosis after intracerebral hemorrhage. Cell Tissue Res. 2017;368(1):13-27.
[8] WANG YX, XU K, SU WL, et al. Therapeutic effects of p75 tumor necrosis factor receptor monoclonal antibody on a rat model of traumatic arthritis. J Surg Res. 2014;186(1):234-239.
[9] WEN X, LIU L, DENG M, et al. Characterization of p75(+) ectomesenchymal stem cells from rat embryonic facial process tissue. Biochem Biophys Res Commun. 2012;427(1):5-10.
[10] ZHAO M, WEN X, LI G, et al. The capacity and biological characteristic of the p75 neurotrophin receptor-positive ectomesenchymal stem cell in vitro. Zhonghua Kou Qiang Yi Xue Za Zhi. 2015;50(2):103-109.
[11] RADA T, REIS RL, GOMES ME. Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential. Stem Cell Rev Rep. 2011;7(1): 64-76.
[12] EDALAT H, HAJEBRAHIMI Z, MOVAHEDIN M, et al. p75NTR suppression in rat bone marrow stromal stem cells significantly reduced their rate of apoptosis during neural differentiation. Neurosci Lett. 2011;498(1): 15-19.
[13] BARCELONA PF, SITARAS N, GALAN A, et al. p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy. J Neurosci. 2016;36(34):8826-8841.
[14] SCHWABE P, SIMON P, KRONBACH Z, et al. A pilot study investigating the histology and growth factor content of human non-union tissue. Int Orthop. 2014;38(12):2623-2629.
[15] RACKWITZ L, REICHERT JC, HAVERSATH M, et al. Cell-based and future therapeutic strategies for femoral head necrosis. Orthopade. 2018; 47(9):770-776.
[16] 张凯,王毅,邢国胜.间充质干细胞的生物学特性及多向分化潜能[J].中国组织工程研究与临床康复,2008,12(3):539-542.
[17] VILAR M, CHARALAMPOPOULOS I, KENCHAPPA RS, et al. Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron. 2009;62(1):72-83.
[18] TOMELLINI E, LAGADEC C, POLAKOWSKA R, et al. Role of p75 neurotrophin receptor in stem cell biology: more than just a marker. Cell Mol Life Sci. 2014;71(13):2467-2481.
[19] SACHS BD, BAILLIE GS, MCCALL JR, et al. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J Cell Biol. 2007;177(6):1119-1132.
[20] ELSHAER SL, EL-REMESSY AB. Implication of the neurotrophin receptor p75NTR in vascular diseases: beyond the eye. Expert Rev Ophthalmol. 2017;12(2):149-158.
[21] MIKAMI Y, ISHII Y, WATANABE N, et al. CD271/p75(NTR) inhibits the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages. Stem Cells Dev. 2011;20(5): 901-913.
[22] KARNES JM, DAFFNER SD, WATKINS CM. Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone. 2015;78:87-93.
[23] KO KI, COIMBRA LS, TIAN C, et al. Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism. Diabetologia. 2015;58(3):633-642.
[24] 朱伦井,段江涛,黄义杰,等.过表达P75神经生长因子受体负向调控骨髓间充质干细胞的成骨分化[J].中国组织工程研究,2020, 24(1): 20-26.
[25] 李家勇,王铭,彭称飞,等.P75NTR在兔骨折不愈合局部组织中的表达及意义[J].中国骨质疏松杂志,2017,23(4):437-440.
[26] ASSIMAKOPOULOU M, KONDYLI M, GATZOUNIS G, et al. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer. 2007;7:202.
[27] SUHL KH, PARK JB, PARK EY, et al. Effect of nerve growth factor and its transforming tyrosine kinase protein and low-affinity nerve growth factor receptors on apoptosis of notochordal cells. Int Orthop. 2012; 36(8):1747-1753.
[28] YANG K, WANG Y, JU Y, et al. p75 neurotrophin receptor regulates differential mineralization of rat ectomesenchymal stem cells. Cell Prolif. 2017;50(1):e12290.
[29] LIU Q, LEI L, YU T, et al. Effect of Brain-Derived Neurotrophic Factor on the Neurogenesis and Osteogenesis in Bone Engineering. Tissue Eng Part A. 2018;24(15-16):1283-1292.